Matrix metalloproteinases in aortic dissection

Shufen Zhou1, Baihui Ma2, Mingyao Luo3

  • 1State Key Laboratory of Cardiovascular Disease, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

Vascular Pharmacology
|August 25, 2024
PubMed

Insights

Matrix metalloproteinases (MMPs) are key enzymes in aortic dissection, driving extracellular matrix degradation. Targeting MMPs shows promise for restoring tissue and reducing dissection incidence.

Area of Science:

  • Cardiovascular Biology
  • Biochemistry
  • Pathology

Background:

  • Aortic dissection is a life-threatening condition linked to aortic wall bleeding or tears.
  • Inflammation, oxidative stress, and extracellular matrix (ECM) degradation are key contributors.
  • Matrix metalloproteinases (MMPs) are crucial enzymes in ECM degradation.

Purpose of the Study:

  • To review the role of MMPs in aortic dissection.
  • To explore MMP expression, regulation, and therapeutic potential.
  • To highlight the importance of understanding MMPs for future interventions.

Main Methods:

  • Review of existing literature on MMPs and aortic dissection.
  • Analysis of MMP expression patterns and regulatory mechanisms.
  • Examination of therapeutic strategies targeting MMPs.

Main Results:

  • MMPs are significantly upregulated in aortic dissection.
  • MMPs play a critical role in ECM degradation and disease pathogenesis.
  • Targeting MMPs may facilitate ECM restoration and reduce dissection incidence.

Conclusions:

  • MMPs are pivotal in aortic dissection pathogenesis.
  • Understanding MMP pathways is essential for developing new treatments.
  • Therapeutic targeting of MMPs offers potential for aortic dissection management.